Amsel Medical Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.7M
Latest Deal Amount
  • Investors
  • 1

Amsel Medical General Information

Description

Manufacturer of an occluder device designed to secure close blood vessels as well as tubular structures during open surgical procedures. The company's device is based on surgical clamping technology that helps blood vessels to heal faster with minimally invasive needle delivery results in secure occlusion similar to that of a transfixion suture and eliminates slippage, enabling medical professionals to treat venous reflux disease and occlude vessels of varying sizes, types, and wall thickness.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 171 Hamilton Street
  • Suite 212
  • Cambridge, MA 02139
  • United States
+1 (857) 000-0000

Amsel Medical Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amsel Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 09-Jan-2020 $1.7M 00.000 000.00 Completed Product In Beta Test
4. Later Stage VC 03-Oct-2018 00000 00.000 000.00 Completed Product In Beta Test
3. Early Stage VC (Series A2) 30-Sep-2016 00.000 00.000 00.000 Completed Product Development
2. Early Stage VC (Series A) 27-Aug-2015 $1.11M $1.38M 00.00 Completed Pre-Clinical Trials
1. Early Stage VC (Series AA) 04-Sep-2014 $266K $266K 00.000 Completed Startup
To view Amsel Medical’s complete valuation and funding history, request access »

Amsel Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-3 000,000 00.000000 00 00.00 00.00 00 00.00 0.00
Series A-2 1,404,900 $0.000100 5% $0.79 $0.79 1x $0.79 10.3%
Series A-1 780,955 $0.000100 5% $0.34 $0.34 1x $0.34 5.73%
To view Amsel Medical’s complete cap table history, request access »

Amsel Medical Executive Team (4)

Name Title Board Seat Contact Info
David Doster Chief Executive Officer
Arnold Miller MD Co-Founder, CMO, President and Board Member
Joseph Gerardi Chief Financial Officer
Raanan Miller Ph.D Co-Founder, Chief Technology Officer & Board Member
To view Amsel Medical’s complete executive team members history, request access »

Amsel Medical Board Members (4)

Name Representing Role Since
Arnold Miller MD Amsel Medical Co-Founder, CMO, President and Board Member 000 0000
Michael Davin Self Board Member 000 0000
Raanan Miller Ph.D Amsel Medical Co-Founder, Chief Technology Officer & Board Member 000 0000
Uri Ben-Yashar Self Board Member 000 0000
To view Amsel Medical’s complete board members history, request access »

Amsel Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amsel Medical Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boston Harbor Angels Angel Group Minority 000 0000 000000 0
To view Amsel Medical’s complete investors history, request access »